Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prev close 6.34 · gapped above the open, never looked back. High/low 6.64 at 3:45 pm ET, 6.64 at 12:45 pm ET.
Cumberland Pharmaceuticals Inc
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“Total revenue by customer for each customer representing 10% or more of consolidated gross revenues are summarized below for the year ended December 31, 2025: 2025 Customer 1 27% Customer 2 25% Customer 3 22%”
$12M relationship
basisCPIX fy2025 · closed 2025-12 $45M
FILING10-K0001087294-26-000020cik 0001087294
“Total revenue by customer for each customer representing 10% or more of consolidated gross revenues are summarized below for the year ended December 31, 2025: 2025 Customer 1 27% Customer 2 25% Customer 3 22%”
$11M relationship
basisCPIX fy2025 · closed 2025-12 $45M
FILING10-K0001087294-26-000020
“Under the terms of the License and Supply Agreement, if a third party receives final approval from the FDA for an ANDA to sell a generic Acetadote product and such third party made such generic version available for purchase in commercial quantities in the United States, we are to supply Perrigo with an Authorized Generic version of our Acetadote product.”
FILING10-K0001087294-26-000020cik 0001087294
“The product's manufacture and supply is overseen by Talicia Holding, Inc., who delivers the product to our warehouse facilities.”
FILING10-K0001087294-26-000020cik 0001087294
“In 2025, Cardinal Health Specialty Solutions exclusively handled our U.S. product logistics activities, including warehousing, shipping, and various other customer activities.”
FILING10-K0001087294-26-000020cik 0001087294
“In 2025, D.B. Pharm continued to purchase supplies of Caldolor and distributed the brand in South Korea.”
FILING10-K0001087294-26-000020cik 0001087294
“Expanded U.S. market access for Vibativ ® through new national group purchasing agreements, including contracts with Premier, Inc. and Vizient, improving availability across hospital systems and strengthening the product's commercial positioning in acute care settings.”
FILING10-K0001087294-26-000020cik 0001087294
“R-Pharm has registered Vibativ in Russia and during 2025, continued to purchase supplies of the product for that market.”
FILING10-K0001087294-26-000020cik 0001087294
“Expanded U.S. market access for Vibativ ® through new national group purchasing agreements, including contracts with Premier, Inc. and Vizient, improving availability across hospital systems and strengthening the product's commercial positioning in acute care settings.”
FILING10-K0001087294-26-000020cik 0001087294
“Under the terms of the agreement, WinHealth will provide development milestone payments and purchase supplies of the products following their registration in China.”
FILING10-K0001087294-26-000020cik 0001087294
“The Company entered into a Sales Agreement (the "Sales Agreement") with H.C. Wainwright & Co., LLC ("H.C. Wainwright") on March 20, 2024, in order to allow the Company to sell shares at market prices.”
FILING10-K0001087294-26-000020cik 0001087294
“On September 5, 2023, the Company entered into a new Revolving Credit Loan Agreement with Pinnacle Bank.”
FILING10-K0001087294-26-000020cik 0001087294
“We have an exclusive, worldwide license to clinical data for intravenous ibuprofen from Vanderbilt University, in consideration for royalty obligations related to Caldolor.”
FILING10-K0001087294-26-000020cik 0001087294
“We have entered into an agreement with PiSA Pharmaceutical for the registration and commercialization of Caldolor in Mexico. Under the terms of the agreement, Cumberland is responsible for providing the product dossier and supplies.”
FILING10-K0001087294-26-000020cik 0001087294
“7. The Broadwest contractual cash obligation began upon commencement in October 2022 and CET began May 2023.”
FILING10-K0001087294-26-000020cik 0001087294
“7. The Broadwest contractual cash obligation began upon commencement in October 2022 and CET began May 2023.”
FILING10-K0001087294-26-000020cik 0001087294
Watchlist prices, news filtered to it, and its next report on your desk.
Cumberland Pharmaceuticals Inc has 7 disclosed suppliers and 9 disclosed customers. Each one is named in an SEC filing, either Cumberland Pharmaceuticals Inc’s own annual report or the counterparty’s, and carries the sentence that discloses it.
CPIX (Cumberland Pharmaceuticals Inc) has 7 disclosed suppliers and 9 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: CAH −1.01%, in healthcare.